Chromatin Raises $10 Million as BP and Unilever Become Investors
This article is for subscribers only.
Chromatin Inc., a closely held agricultural biotechnology company, said venture capital units of BP Plc and Unilever NV have become strategic investors.
The companies were among five that contributed to a $10 million Series D financing round, Chicago-based Chromatin said today in a statement.